Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Accessible Cancer Care


Faced with shortages of inexpensive essential medicines and increasing prices of innovative, potentially curative therapies reaching the clinic, we need to rethink the allocation of finite resources to secure the best possible care for all cancer patients while reducing the number of people who develop the disease in the future. By offering independent decision-making tools like the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) to support sustainability in oncology, developing locally adapted, value-based models of medicine reimbursement and targeting health inequalities in high and low-income settings alike, we can ensure that optimal care becomes accessible to everyone, everywhere.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.